Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 4.5 - 13 mm: medical device reports filed with FDA

1,473 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,473
device reports naming the brand
0% of all MAUDE reports · about 208 a year
168
reports, 12 months to August 2026
227 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,473 reports that name the brand "OsseoSpeed TX 4.5 - 13 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

168 reports arrived in the 12 months to August 2026, down 26% from 227 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (36.9%), loss of osseointegration (34%) and failure to osseointegrate (23.7%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02651Sep 2021: 13Oct 2021: 13Nov 2021: 11Dec 2021: 142022Jan 2022: 28Feb 2022: 21Mar 2022: 15Apr 2022: 30May 2022: 15Jun 2022: 14Jul 2022: 19Aug 2022: 15Sep 2022: 9Oct 2022: 11Nov 2022: 13Dec 2022: 162023Jan 2023: 8Feb 2023: 15Mar 2023: 29Apr 2023: 10May 2023: 12Jun 2023: 25Jul 2023: 32Aug 2023: 51Sep 2023: 24Oct 2023: 14Nov 2023: 20Dec 2023: 92024Jan 2024: 17Feb 2024: 19Mar 2024: 9Apr 2024: 16May 2024: 15Jun 2024: 12Jul 2024: 21Aug 2024: 21Sep 2024: 16Oct 2024: 25Nov 2024: 12Dec 2024: 142025Jan 2025: 15Feb 2025: 18Mar 2025: 35Apr 2025: 5May 2025: 21Jun 2025: 14Jul 2025: 21Aug 2025: 31Sep 2025: 8Oct 2025: 6Nov 2025: 13Dec 2025: 102026Jan 2026: 21Feb 2026: 8Mar 2026: 16Apr 2026: 22May 2026: 9Jun 2026: 20Jul 2026: 22Aug 2026: 13

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02234452019: 4820192021: 44520212022: 20620222023: 24920232024: 19720242025: 19720252026: 1312026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,473
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,473
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem54336.9%7.7%
Loss of osseointegration50134%22.4%
Failure to osseointegrate34923.7%62.8%
Fracturea broken bone865.8%1.6%
Loosening of implant not related to bone-ingrowth70.5%0.1%
Crackthe device cracked50.3%0%
Malposition of device30.2%0.1%
Patient-device incompatibilitythe device did not suit the patient20.1%0%
Device dislodged or dislocated10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,47299.9%
Inflammationinflammation21314.5%
Pocket erosion966.5%
Osteolysis795.4%
Implant pain20.1%
Painpain, site not specified20.1%
Sinus perforation20.1%
Numbnessnumbness10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 4.5 - 13 mmProduct code DZEAll MAUDE reports
Reports1,4733,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 4.5 - 13 mm reports

How many FDA reports name OsseoSpeed TX 4.5 - 13 mm?

1,473 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 168 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (36.9%), loss of osseointegration (34%), failure to osseointegrate (23.7%), fracture (5.8%) and loosening of implant not related to bone-ingrowth (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 4.5 - 13 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.